EMEA (Europe, Middle East and Africa) Human Insulin Market Report 2018

March 2018 | 104 pages | ID: EE19F885084QEN
QYResearch

Abstracts

In this report, the EMEA Human Insulin market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Kg), revenue (Million USD), market share and growth rate of Human Insulin for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Human Insulin market competition by top manufacturers/players, with Human Insulin sales volume (Kg), price (USD/G), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi (France)
• Eli Lilly and Company (U.S.)
• Biocon Ltd. (India)
• Julphar (U.A.E.)
• Ypsomed AG (Switzerland)
• Becton
• Dickinson and Company (U.S.)
• Wockhardt Ltd. (India)
• B. Braun Meselgen AG (Switzerland)
• Biodel Inc(U.S.)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Short Acting Human Insulin
• Intermediate Acting Human Insulin
• Premixed Human Insulin

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Insulin Dependent Diabetes Mellitus
• Non-Insulin Dependent Diabetes Mellitus

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Human Insulin Market Report 2018

1 HUMAN INSULIN OVERVIEW

1.1 Product Overview and Scope of Human Insulin
1.2 Classification of Human Insulin
  1.2.1 EMEA Human Insulin Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Human Insulin Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Short Acting Human Insulin
  1.2.4 Intermediate Acting Human Insulin
  1.2.5 Premixed Human Insulin
1.3 EMEA Human Insulin Market by Application/End Users
  1.3.1 EMEA Human Insulin Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Insulin Dependent Diabetes Mellitus
  1.3.3 Non-Insulin Dependent Diabetes Mellitus
1.4 EMEA Human Insulin Market by Region
  1.4.1 EMEA Human Insulin Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Human Insulin (2013-2025)
  1.5.1 EMEA Human Insulin Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Human Insulin Revenue and Growth Rate (2013-2025)

2 EMEA HUMAN INSULIN COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Human Insulin Market Competition by Players/Manufacturers
  2.1.1 EMEA Human Insulin Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Human Insulin Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Human Insulin Sale Price by Players (2013-2018)
2.2 EMEA Human Insulin (Volume and Value) by Type/Product Category
  2.2.1 EMEA Human Insulin Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Human Insulin Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Human Insulin Sale Price by Type (2013-2018)
2.3 EMEA Human Insulin (Volume) by Application
2.4 EMEA Human Insulin (Volume and Value) by Region
  2.4.1 EMEA Human Insulin Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Human Insulin Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Human Insulin Sales Price by Region (2013-2018)

3 EUROPE HUMAN INSULIN (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Human Insulin Sales and Value (2013-2018)
  3.1.1 Europe Human Insulin Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Human Insulin Revenue and Growth Rate (2013-2018)
3.2 Europe Human Insulin Sales and Market Share by Type
3.3 Europe Human Insulin Sales and Market Share by Application
3.4 Europe Human Insulin Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Human Insulin Sales Volume by Countries (2013-2018)
  3.4.2 Europe Human Insulin Revenue by Countries (2013-2018)
  3.4.3 Germany Human Insulin Sales and Growth Rate (2013-2018)
  3.4.4 France Human Insulin Sales and Growth Rate (2013-2018)
  3.4.5 UK Human Insulin Sales and Growth Rate (2013-2018)
  3.4.6 Russia Human Insulin Sales and Growth Rate (2013-2018)
  3.4.7 Italy Human Insulin Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Human Insulin Sales and Growth Rate (2013-2018)

4 MIDDLE EAST HUMAN INSULIN (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Human Insulin Sales and Value (2013-2018)
  4.1.1 Middle East Human Insulin Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Human Insulin Revenue and Growth Rate (2013-2018)
4.2 Middle East Human Insulin Sales and Market Share by Type
4.3 Middle East Human Insulin Sales and Market Share by Application
4.4 Middle East Human Insulin Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Human Insulin Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Human Insulin Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Human Insulin Sales and Growth Rate (2013-2018)
  4.4.4 Israel Human Insulin Sales and Growth Rate (2013-2018)
  4.4.5 UAE Human Insulin Sales and Growth Rate (2013-2018)
  4.4.6 Iran Human Insulin Sales and Growth Rate (2013-2018)

5 AFRICA HUMAN INSULIN (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Human Insulin Sales and Value (2013-2018)
  5.1.1 Africa Human Insulin Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Human Insulin Revenue and Growth Rate (2013-2018)
5.2 Africa Human Insulin Sales and Market Share by Type
5.3 Africa Human Insulin Sales and Market Share by Application
5.4 Africa Human Insulin Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Human Insulin Sales Volume by Countries (2013-2018)
  5.4.2 Africa Human Insulin Revenue by Countries (2013-2018)
  5.4.3 South Africa Human Insulin Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Human Insulin Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Human Insulin Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Human Insulin Sales and Growth Rate (2013-2018)

6 EMEA HUMAN INSULIN MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Sanofi (France)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Insulin Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi (France) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Eli Lilly and Company (U.S.)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Human Insulin Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Eli Lilly and Company (U.S.) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Biocon Ltd. (India)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Human Insulin Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Biocon Ltd. (India) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Julphar (U.A.E.)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Human Insulin Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Julphar (U.A.E.) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Ypsomed AG (Switzerland)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Human Insulin Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Ypsomed AG (Switzerland) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Becton
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Human Insulin Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Becton Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Dickinson and Company (U.S.)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Human Insulin Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Dickinson and Company (U.S.) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Wockhardt Ltd. (India)
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Human Insulin Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Wockhardt Ltd. (India) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 B. Braun Meselgen AG (Switzerland)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Human Insulin Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 B. Braun Meselgen AG (Switzerland) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Biodel Inc(U.S.)
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Human Insulin Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Biodel Inc(U.S.) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 HUMAN INSULIN MANUFACTURING COST ANALYSIS

7.1 Human Insulin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Insulin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Insulin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Insulin Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA HUMAN INSULIN MARKET FORECAST (2018-2025)

11.1 EMEA Human Insulin Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Human Insulin Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Human Insulin Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Human Insulin Price and Trend Forecast (2018-2025)
11.2 EMEA Human Insulin Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Human Insulin Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Human Insulin Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Human Insulin Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Human Insulin Sales Forecast by Type (2018-2025)
11.7 EMEA Human Insulin Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Insulin
Figure EMEA Human Insulin Sales Volume (Kg) by Type (2013-2025)
Figure EMEA Human Insulin Sales Volume Market Share by Type (Product Category) in 2017
Figure Short Acting Human Insulin Product Picture
Figure Intermediate Acting Human Insulin Product Picture
Figure Premixed Human Insulin Product Picture
Figure EMEA Human Insulin Sales Volume (Kg) by Application (2013-2025)
Figure EMEA Sales Market Share of Human Insulin by Application in 2017
Figure Insulin Dependent Diabetes Mellitus Examples
Table Key Downstream Customer in Insulin Dependent Diabetes Mellitus
Figure Non-Insulin Dependent Diabetes Mellitus Examples
Table Key Downstream Customer in Non-Insulin Dependent Diabetes Mellitus
Figure EMEA Human Insulin Market Size (Million USD) by Region (2013-2025)
Figure Europe Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Human Insulin Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Human Insulin Revenue (Million USD) Status and Forecast by Countries
Figure Africa Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Human Insulin Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Human Insulin Sales Volume and Growth Rate (2013-2025)
Figure EMEA Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Human Insulin Market Major Players Product Sales Volume (Kg) (2013-2018)
Table EMEA Human Insulin Sales Volume (Kg) of Major Players (2013-2018)
Table EMEA Human Insulin Sales Share by Players (2013-2018)
Figure 2017 Human Insulin Sales Share by Players
Figure 2017 Human Insulin Sales Share by Players
Figure EMEA Human Insulin Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Human Insulin Revenue (Million USD) by Players (2013-2018)
Table EMEA Human Insulin Revenue Share by Players (2013-2018)
Table 2017 EMEA Human Insulin Revenue Share by Players
Table 2017 EMEA Human Insulin Revenue Share by Players
Table EMEA Human Insulin Sale Price (USD/G) by Players (2013-2018)
Table EMEA Human Insulin Sales (Kg) and Market Share by Type (2013-2018)
Table EMEA Human Insulin Sales Share by Type (2013-2018)
Figure Sales Market Share of Human Insulin by Type (2013-2018)
Figure EMEA Human Insulin Sales Market Share by Type (2013-2018)
Table EMEA Human Insulin Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Human Insulin Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Human Insulin by Type in 2017
Table EMEA Human Insulin Sale Price (USD/G) by Type (2013-2018)
Table EMEA Human Insulin Sales (Kg) and Market Share by Application (2013-2018)
Table EMEA Human Insulin Sales Share by Application (2013-2018)
Figure Sales Market Share of Human Insulin by Application (2013-2018)
Figure EMEA Human Insulin Sales Market Share by Application in 2017
Table EMEA Human Insulin Sales (Kg) and Market Share by Region (2013-2018)
Table EMEA Human Insulin Sales Share by Region (2013-2018)
Figure Sales Market Share of Human Insulin by Region (2013-2018)
Figure EMEA Human Insulin Sales Market Share in 2017
Table EMEA Human Insulin Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Human Insulin Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Human Insulin by Region (2013-2018)
Figure EMEA Human Insulin Revenue Market Share Regions in 2017
Table EMEA Human Insulin Sales Price (USD/G) by Region (2013-2018)
Figure Europe Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Europe Human Insulin Revenue and Growth Rate (2013-2018)
Table Europe Human Insulin Sales (Kg) by Type (2013-2018)
Table Europe Human Insulin Market Share by Type (2013-2018)
Figure Europe Human Insulin Market Share by Type in 2017
Table Europe Human Insulin Sales (Kg) by Application (2013-2018)
Table Europe Human Insulin Market Share by Application (2013-2018)
Figure Europe Human Insulin Market Share by Application in 2017
Table Europe Human Insulin Sales (Kg) by Countries (2013-2018)
Table Europe Human Insulin Sales Market Share by Countries (2013-2018)
Figure Europe Human Insulin Sales Market Share by Countries (2013-2018)
Figure Europe Human Insulin Sales Market Share by Countries in 2017
Table Europe Human Insulin Revenue (Million USD) by Countries (2013-2018)
Table Europe Human Insulin Revenue Market Share by Countries (2013-2018)
Figure Europe Human Insulin Revenue Market Share by Countries (2013-2018)
Figure Europe Human Insulin Revenue Market Share by Countries in 2017
Figure Germany Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure France Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure UK Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Russia Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Italy Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Benelux Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Middle East Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Middle East Human Insulin Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Human Insulin Sales (Kg) by Type (2013-2018)
Table Middle East Human Insulin Market Share by Type (2013-2018)
Figure Middle East Human Insulin Market Share by Type (2013-2018)
Table Middle East Human Insulin Sales (Kg) by Applications (2013-2018)
Table Middle East Human Insulin Market Share by Applications (2013-2018)
Figure Middle East Human Insulin Sales Market Share by Application in 2017
Table Middle East Human Insulin Sales Volume (Kg) by Countries (2013-2018)
Table Middle East Human Insulin Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Human Insulin Sales Volume Market Share by Countries in 2017
Table Middle East Human Insulin Revenue (Million USD) by Countries (2013-2018)
Table Middle East Human Insulin Revenue Market Share by Countries (2013-2018)
Figure Middle East Human Insulin Revenue Market Share by Countries (2013-2018)
Figure Middle East Human Insulin Revenue Market Share by Countries in 2017
Figure Saudi Arabia Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Israel Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure UAE Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Iran Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Africa Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Africa Human Insulin Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Human Insulin Sales (Kg) by Type (2013-2018)
Table Africa Human Insulin Sales Market Share by Type (2013-2018)
Figure Africa Human Insulin Sales Market Share by Type (2013-2018)
Figure Africa Human Insulin Sales Market Share by Type in 2017
Table Africa Human Insulin Sales (Kg) by Application (2013-2018)
Table Africa Human Insulin Sales Market Share by Application (2013-2018)
Figure Africa Human Insulin Sales Market Share by Application (2013-2018)
Table Africa Human Insulin Sales Volume (Kg) by Countries (2013-2018)
Table Africa Human Insulin Sales Market Share by Countries (2013-2018)
Figure Africa Human Insulin Sales Market Share by Countries (2013-2018)
Figure Africa Human Insulin Sales Market Share by Countries in 2017
Table Africa Human Insulin Revenue (Million USD) by Countries (2013-2018)
Table Africa Human Insulin Revenue Market Share by Countries (2013-2018)
Figure Africa Human Insulin Revenue Market Share by Countries (2013-2018)
Figure Africa Human Insulin Revenue Market Share by Countries in 2017
Figure South Africa Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Nigeria Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Egypt Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Algeria Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Table Sanofi (France) Human Insulin Basic Information List
Table Sanofi (France) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Sanofi (France) Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Sanofi (France) Human Insulin Sales Market Share in EMEA (2013-2018)
Figure Sanofi (France) Human Insulin Revenue Market Share in EMEA (2013-2018)
Table Eli Lilly and Company (U.S.) Human Insulin Basic Information List
Table Eli Lilly and Company (U.S.) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Eli Lilly and Company (U.S.) Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Eli Lilly and Company (U.S.) Human Insulin Sales Market Share in EMEA (2013-2018)
Figure Eli Lilly and Company (U.S.) Human Insulin Revenue Market Share in EMEA (2013-2018)
Table Biocon Ltd. (India) Human Insulin Basic Information List
Table Biocon Ltd. (India) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Biocon Ltd. (India) Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Biocon Ltd. (India) Human Insulin Sales Market Share in EMEA (2013-2018)
Figure Biocon Ltd. (India) Human Insulin Revenue Market Share in EMEA (2013-2018)
Table Julphar (U.A.E.) Human Insulin Basic Information List
Table Julphar (U.A.E.) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Julphar (U.A.E.) Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Julphar (U.A.E.) Human Insulin Sales Market Share in EMEA (2013-2018)
Figure Julphar (U.A.E.) Human Insulin Revenue Market Share in EMEA (2013-2018)
Table Ypsomed AG (Switzerland) Human Insulin Basic Information List
Table Ypsomed AG (Switzerland) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Ypsomed AG (Switzerland) Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Ypsomed AG (Switzerland) Human Insulin Sales Market Share in EMEA (2013-2018)
Figure Ypsomed AG (Switzerland) Human Insulin Revenue Market Share in EMEA (2013-2018)
Table Becton Human Insulin Basic Information List
Table Becton Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Becton Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Becton Human Insulin Sales Market Share in EMEA (2013-2018)
Figure Becton Human Insulin Revenue Market Share in EMEA (2013-2018)
Table Dickinson and Company (U.S.) Human Insulin Basic Information List
Table Dickinson and Company (U.S.) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Dickinson and Company (U.S.) Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Dickinson and Company (U.S.) Human Insulin Sales Market Share in EMEA (2013-2018)
Figure Dickinson and Company (U.S.) Human Insulin Revenue Market Share in EMEA (2013-2018)
Table Wockhardt Ltd. (India) Human Insulin Basic Information List
Table Wockhardt Ltd. (India) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Wockhardt Ltd. (India) Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Wockhardt Ltd. (India) Human Insulin Sales Market Share in EMEA (2013-2018)
Figure Wockhardt Ltd. (India) Human Insulin Revenue Market Share in EMEA (2013-2018)
Table B. Braun Meselgen AG (Switzerland) Human Insulin Basic Information List
Table B. Braun Meselgen AG (Switzerland) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure B. Braun Meselgen AG (Switzerland) Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure B. Braun Meselgen AG (Switzerland) Human Insulin Sales Market Share in EMEA (2013-2018)
Figure B. Braun Meselgen AG (Switzerland) Human Insulin Revenue Market Share in EMEA (2013-2018)
Table Biodel Inc(U.S.) Human Insulin Basic Information List
Table Biodel Inc(U.S.) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Biodel Inc(U.S.) Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Biodel Inc(U.S.) Human Insulin Sales Market Share in EMEA (2013-2018)
Figure Biodel Inc(U.S.) Human Insulin Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Insulin
Figure Manufacturing Process Analysis of Human Insulin
Figure Human Insulin Industrial Chain Analysis
Table Raw Materials Sources of Human Insulin Major Manufacturers in 2017
Table Major Buyers of Human Insulin
Table Distributors/Traders List
Figure EMEA Human Insulin Sales (Kg) and Growth Rate Forecast (2018-2025)
Figure EMEA Human Insulin Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Human Insulin Price (USD/G) and Trend Forecast (2018-2025)
Table EMEA Human Insulin Sales (Kg) Forecast by Region (2018-2025)
Figure EMEA Human Insulin Sales Market Share Forecast by Region (2018-2025)
Table EMEA Human Insulin Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Human Insulin Revenue Market Share Forecast by Region (2018-2025)
Table Europe Human Insulin Sales (Kg) Forecast by Countries (2018-2025)
Figure Europe Human Insulin Sales Market Share Forecast by Countries (2018-2025)
Table Europe Human Insulin Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Human Insulin Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Human Insulin Sales (Kg) Forecast by Countries (2018-2025)
Figure Middle East Human Insulin Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Human Insulin Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Human Insulin Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Human Insulin Sales (Kg) Forecast by Countries (2018-2025)
Figure Africa Human Insulin Sales Market Share Forecast by Countries (2018-2025)
Table Africa Human Insulin Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Human Insulin Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Human Insulin Sales (Kg) Forecast by Type (2018-2025)
Figure EMEA Human Insulin Sales Market Share Forecast by Type (2018-2025)
Table EMEA Human Insulin Sales (Kg) Forecast by Application (2018-2025)
Figure EMEA Human Insulin Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources